Literature DB >> 15803627

The ALTEA/ALTEINO projects: studying functional effects of microgravity and cosmic radiation.

L Narici1, F Belli, V Bidoli, M Casolino, M P De Pascale, L Di Fino, G Furano, I Modena, A Morselli, P Picozza, E Reali, A Rinaldi, D Ruggieri, R Sparvoli, V Zaconte, W G Sannita, S Carozzo, S Licoccia, P Romagnoli, E Traversa, V Cotronei, M Vazquez, J Miller, V P Salnitskii, O I Shevchenko, V P Petrov, K A Trukhanov, A Galper, A Khodarovich, M G Korotkov, A Popov, N Vavilov, S Avdeev, M Boezio, W Bonvicini, A Vacchi, N Zampa, G Mazzenga, M Ricci, P Spillantini, G Castellini, R Vittori, P Carlson, C Fuglesang, D Schardt.   

Abstract

The ALTEA project investigates the risks of functional brain damage induced by particle radiation in space. A modular facility (the ALTEA facility) is being implemented and will be operated in the International Space Station (ISS) to record electrophysiological and behavioral descriptors of brain function and to monitor their time dynamics and correlation with particles and space environment. The focus of the program will be on abnormal visual perceptions (often reported as "light flashes" by astronauts) and the impact on retinal and brain visual structures of particle in microgravity conditions. The facility will be made available to the international scientific community for human neurophysiological, electrophysiological and psychophysics experiments, studies on particle fluxes, and dosimetry. A precursor of ALTEA (the 'Alteino' project) helps set the experimental baseline for the ALTEA experiments, while providing novel information on the radiation environment onboard the ISS and on the brain electrophysiology of the astronauts during orbital flights. Alteino was flown to the ISS on the Soyuz TM34 as part of mission Marco Polo. Controlled ground experiments using mice and accelerator beams complete the experimental strategy of ALTEA. We present here the status of progress of the ALTEA project and preliminary results of the Alteino study on brain dynamics, particle fluxes and abnormal visual perceptions. c2004 COSPAR. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  NASA Discipline Radiation Health; NASA Program Biomedical Research and Countermeasures; Non-NASA Center

Mesh:

Year:  2004        PMID: 15803627     DOI: 10.1016/j.asr.2003.09.052

Source DB:  PubMed          Journal:  Adv Space Res        ISSN: 0273-1177            Impact factor:   2.152


  6 in total

1.  Tests of shielding effectiveness of Kevlar and Nextel onboard the International Space Station and the Foton-M3 capsule.

Authors:  M Pugliese; V Bengin; M Casolino; V Roca; A Zanini; M Durante
Journal:  Radiat Environ Biophys       Date:  2010-04-03       Impact factor: 1.925

Review 2.  Radiation Measurements Performed with Active Detectors Relevant for Human Space Exploration.

Authors:  Livio Narici; Thomas Berger; Daniel Matthiä; Günther Reitz
Journal:  Front Oncol       Date:  2015-12-08       Impact factor: 6.244

Review 3.  Mechanisms of phosphenes in irradiated patients.

Authors:  Thibaud Mathis; Stephane Vignot; Cecila Leal; Jean-Pierre Caujolle; Celia Maschi; Martine Mauget-Faÿsse; Laurent Kodjikian; Stéphanie Baillif; Joel Herault; Juliette Thariat
Journal:  Oncotarget       Date:  2017-06-28

4.  Performances of Kevlar and Polyethylene as radiation shielding on-board the International Space Station in high latitude radiation environment.

Authors:  Livio Narici; Marco Casolino; Luca Di Fino; Marianna Larosa; Piergiorgio Picozza; Alessandro Rizzo; Veronica Zaconte
Journal:  Sci Rep       Date:  2017-05-10       Impact factor: 4.379

Review 5.  Dose-Effects Models for Space Radiobiology: An Overview on Dose-Effect Relationships.

Authors:  Lidia Strigari; Silvia Strolin; Alessio Giuseppe Morganti; Alessandro Bartoloni
Journal:  Front Public Health       Date:  2021-11-08

6.  Personalized medicine in human space flight: using Omics based analyses to develop individualized countermeasures that enhance astronaut safety and performance.

Authors:  Michael A Schmidt; Thomas J Goodwin
Journal:  Metabolomics       Date:  2013-06-27       Impact factor: 4.290

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.